Social media can predict the success of a new drug launch much faster than traditional methods. Many pharmaceutical companies try to measure the success of their launch based on weekly script trends. The difference between social media data and data derived from prescriptions is significant: social media data can predict the future, while script data [...]
Pharmaceutical companies spend billions of dollars developing name-brand drugs, with the understanding that they will earn back that investment during the time they sell the drug under patent protection. But what happens when a generic drug manufacturer can provide a similar drug at a much lower cost, without infringing on the patent? If the generic [...]
The FDA is forcing dosage reductions and label changes on zolpidem sleep aids due to their morning drowsiness effect which may be responsible for car accidents. Reports in the New York Times and other leading publications detail a driving simulation study done on the drug Intermezzo, which showed impaired driving even eight hours after taking [...]
Most pharmaceutical companies have a page on Wikipedia, and it is an important component of your online presence. But is yours ready for prime time? Wikipedia is hard to ignore. It’s the collaborative reference website which attracts around 470 million unique visitors monthly. It always places very high in search engine results. And it’s used [...]
Before the New Year our pharmaceutical and agency customers indicated to us that this year they intend to “incorporate the patient voice into their work.” Voices are meant not only to be heard, but engaged with, which means opening up a dialogue. Such a conversation can bring value to both sides through greater understanding. Your [...]
The British Medical Journal made waves recently by publishing an editorial stating that they will no longer publish clinical trial results unless the sponsor agrees to disclose anonymised patient level data starting now, January 2013. Pharma industry advocates have countered that this could unwittingly expose patients’ personal information, or undermine a company’s competitive advantage thus [...]
Hearing the “Patient Voice” is a critical element in understanding how real users of prescription medications – the end customers – feel about them. When gathering brand intelligence, there are several methods for incorporating patient experiences – surveys, focus groups, and in recent years, social media. Surveys Typically administered over the phone or more recently [...]
John Mack, aka Pharmaguy, kicked off Day 2 of Health 2.0 by interviewing Treato’s CEO and co-founder Gideon Mantel about real time patient intelligence on his Pharma Marketing podcast. In the interview, Gideon talks about just how big Treato’s definition of big data is, what the difference is between Treato.com (advertising-free site for patients) and Treato [...]
Health 2.0 started yesterday, and here are some initial thoughts and observations based on the iPharma session in which we participated. Around 400 people came to the six pre-conference events, one of which was the iPharma session. Marco Smit from #health2con opened the iPharma session with a quick survey of the 50-60 people in the [...]
Just in case you missed the Google alert, tweet, LinkedIn or Facebook notification, it’s now official – the new, professional version of Treato, aka Treato Pharma, is available. Treato Pharma interprets vasts amounts of patient experiences from blogs and forums into an efficient, user-friendly format for pharmaceutical marketers and agencies, to enable them to incorporate [...]
